Riethdorf S - Search Results

1

Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.

Hohmann N, Sprick MR, Pohl M, Ahmed A, Burhenne J, Kirchner M, Le Cornet L, Kratzmann M, Hajda J, Stenzinger A, Steindorf K, Delorme S, Schlemmer HP, Riethdorf S, van Schaik R, Pantel K, Siveke J, Seufferlein T, Jäger D, Haefeli WE, Trumpp A, Springfeld C. Hohmann N, et al. Among authors: riethdorf s. Clin Transl Sci. 2023 Dec;16(12):2483-2493. doi: 10.1111/cts.13661. Epub 2023 Nov 3. Clin Transl Sci. 2023. PMID: 37920921 Free PMC article.

2

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.

Müller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Jänicke F, Pantel K. Müller V, et al. Among authors: riethdorf s. Clin Cancer Res. 2005 May 15;11(10):3678-85. doi: 10.1158/1078-0432.CCR-04-2469. Clin Cancer Res. 2005. PMID: 15897564

3

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.

Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K. Willipinski-Stapelfeldt B, et al. Among authors: riethdorf s. Clin Cancer Res. 2005 Nov 15;11(22):8006-14. doi: 10.1158/1078-0432.CCR-05-0632. Clin Cancer Res. 2005. PMID: 16299229

4

High incidence of EMMPRIN expression in human tumors.

Riethdorf S, Reimers N, Assmann V, Kornfeld JW, Terracciano L, Sauter G, Pantel K. Riethdorf S, et al. Int J Cancer. 2006 Oct 15;119(8):1800-10. doi: 10.1002/ijc.22062. Int J Cancer. 2006. PMID: 16721788 Free article.

5

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Riethdorf S, et al. Clin Cancer Res. 2007 Feb 1;13(3):920-8. doi: 10.1158/1078-0432.CCR-06-1695. Clin Cancer Res. 2007. PMID: 17289886

6

Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.

Riethdorf S, Pantel K. Riethdorf S, et al. Pathobiology. 2008;75(2):140-8. doi: 10.1159/000123852. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544969 Free article. Review.

7

Review: Biological relevance of disseminated tumor cells in cancer patients.

Riethdorf S, Wikman H, Pantel K. Riethdorf S, et al. Int J Cancer. 2008 Nov 1;123(9):1991-2006. doi: 10.1002/ijc.23825. Int J Cancer. 2008. PMID: 18712708 Free article. Review.

8

Pathology: are circulating tumor cells predictive of overall survival?

Pantel K, Riethdorf S. Pantel K, et al. Among authors: riethdorf s. Nat Rev Clin Oncol. 2009 Apr;6(4):190-1. doi: 10.1038/nrclinonc.2009.23. Nat Rev Clin Oncol. 2009. PMID: 19333222 No abstract available.

9

Cancer micrometastases.

Pantel K, Alix-Panabières C, Riethdorf S. Pantel K, et al. Among authors: riethdorf s. Nat Rev Clin Oncol. 2009 Jun;6(6):339-51. doi: 10.1038/nrclinonc.2009.44. Nat Rev Clin Oncol. 2009. PMID: 19399023 Review.

10

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.

Riethdorf S, Pantel K. Riethdorf S, et al. Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S10. doi: 10.1186/bcr2429. Epub 2009 Dec 18. Breast Cancer Res. 2009. PMID: 20030861 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page